About Oepgroup
op nanopharma is a joint investment of orient europharma and nanocarrier co., ltd., in japan and mainly develops oncology drugs including micelplatin, nanopaclitaxel and yq1 for head... Read more
op nanopharma is a joint investment of orient europharma and nanocarrier co., ltd., in japan and mainly develops oncology drugs including micelplatin, nanopaclitaxel and yq1 for head... Read more